Literature DB >> 20053377

Galectin-3 contributes to neonatal hypoxic-ischemic brain injury.

Christina Doverhag1, Maj Hedtjärn, Françoise Poirier, Carina Mallard, Henrik Hagberg, Anna Karlsson, Karin Sävman.   

Abstract

Inflammation induced by hypoxia-ischemia (HI) contributes to the development of injury in the newborn brain. In this study, we investigated the role of galectin-3, a novel inflammatory mediator, in the inflammatory response and development of brain injury in a mouse model for neonatal HI. Galectin-3 gene and protein expression was increased after injury and galectin-3 was located in activated microglia/macrophages. Galectin-3-deficient mice (gal3-/-) were protected from injury particularly in hippocampus and striatum. Microglia accumulation was increased in the gal3-/- mice but accompanied by decreased levels of total matrix metalloproteinase (MMP)-9 and nitrotyrosine. The protection and increase in microglial infiltration was more pronounced in male gal3-/- mice. Trophic factors and apoptotic markers did not significantly differ between groups. In conclusion, galectin-3 contributes to neonatal HI injury particularly in male mice. Our results indicate that galectin-3 exerts its effect by modulating the inflammatory response. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20053377     DOI: 10.1016/j.nbd.2009.12.024

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  60 in total

Review 1.  Towards molecular mechanisms regulating the expression of galectins in cancer cells under microenvironmental stress conditions.

Authors:  Alexander V Timoshenko
Journal:  Cell Mol Life Sci       Date:  2015-08-06       Impact factor: 9.261

Review 2.  Modeling Ischemia in the Immature Brain: How Translational Are Animal Models?

Authors:  Carina Mallard; Zinaida S Vexler
Journal:  Stroke       Date:  2015-08-13       Impact factor: 7.914

Review 3.  Pathophysiology and neuroprotection of global and focal perinatal brain injury: lessons from animal models.

Authors:  Luigi Titomanlio; David Fernández-López; Lucilla Manganozzi; Raffaella Moretti; Zinaida S Vexler; Pierre Gressens
Journal:  Pediatr Neurol       Date:  2015-01-31       Impact factor: 3.372

4.  Structure of a tetrameric galectin from Cinachyrella sp. (ball sponge).

Authors:  Douglas M Freymann; Yuka Nakamura; Pamela J Focia; Ryuichi Sakai; Geoffrey T Swanson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2012-08-18

5.  Increased fibrinogen, D-dimer and galectin-3 levels in patients with migraine.

Authors:  Yavuz Yucel; Halis Tanriverdi; Adalet Arıkanoglu; Sefer Varol; Ibrahim Kaplan; Esref Akil; Tahsin Celepkolu; Ertugrul Uzar
Journal:  Neurol Sci       Date:  2013-09-22       Impact factor: 3.307

6.  Neuroprotective Effect of 3-(Naphthalen-2-Yl(Propoxy)Methyl)Azetidine Hydrochloride on Brain Ischaemia/Reperfusion Injury.

Authors:  Eun-A Kim; Jung-Min Na; Jiae Kim; Soo Young Choi; Jee-Yin Ahn; Sung-Woo Cho
Journal:  J Neuroimmune Pharmacol       Date:  2017-02-28       Impact factor: 4.147

Review 7.  Baby STEPS: a giant leap for cell therapy in neonatal brain injury.

Authors:  Cesar V Borlongan; Michael D Weiss
Journal:  Pediatr Res       Date:  2011-07       Impact factor: 3.756

Review 8.  The myth of the immature barrier systems in the developing brain: role in perinatal brain injury.

Authors:  Carina Mallard; C Joakim Ek; Zinaida S Vexler
Journal:  J Physiol       Date:  2018-04-16       Impact factor: 5.182

9.  Role of galectin-3 in acetaminophen-induced hepatotoxicity and inflammatory mediator production.

Authors:  Ana-Cristina Dragomir; Richard Sun; Vladimir Mishin; LeRoy B Hall; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Sci       Date:  2012-03-29       Impact factor: 4.849

10.  Galectin-3 enhances angiogenic and migratory potential of microglial cells via modulation of integrin linked kinase signaling.

Authors:  Umadevi V Wesley; Raghu Vemuganti; Emine R Ayvaci; Robert J Dempsey
Journal:  Brain Res       Date:  2012-12-14       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.